Ashok V. Purandare

1.1k total citations
27 papers, 797 citations indexed

About

Ashok V. Purandare is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Ashok V. Purandare has authored 27 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Organic Chemistry and 10 papers in Oncology. Recurrent topics in Ashok V. Purandare's work include Cytokine Signaling Pathways and Interactions (5 papers), Epigenetics and DNA Methylation (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Ashok V. Purandare is often cited by papers focused on Cytokine Signaling Pathways and Interactions (5 papers), Epigenetics and DNA Methylation (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Ashok V. Purandare collaborates with scholars based in United States, Germany and Sweden. Ashok V. Purandare's co-authors include Michael A. Poss, Wayne Vaccaro, John E. Somerville, Sesha Natarajan, Honghe Wan, Lata Jayaraman, Jieping Geng, Suhong Pang, Tram Huynh and Matthew V. Lorenzi and has published in prestigious journals such as Journal of the American Chemical Society, Blood and Cancer Research.

In The Last Decade

Ashok V. Purandare

26 papers receiving 752 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashok V. Purandare United States 16 540 255 179 98 40 27 797
F. Gessier Switzerland 16 559 1.0× 329 1.3× 213 1.2× 100 1.0× 45 1.1× 25 897
Krishna G. Vijayendran United States 5 604 1.1× 195 0.8× 298 1.7× 62 0.6× 22 0.6× 5 847
Shendong Yuan United States 11 253 0.5× 176 0.7× 88 0.5× 62 0.6× 42 1.1× 20 524
Fabrice Pierre France 11 629 1.2× 254 1.0× 202 1.1× 42 0.4× 48 1.2× 17 930
Shaughnessy Robinson United States 13 387 0.7× 239 0.9× 114 0.6× 128 1.3× 16 0.4× 17 665
Cornelis P. Vlaar Puerto Rico 14 476 0.9× 229 0.9× 124 0.7× 38 0.4× 21 0.5× 44 812
Laura L. Rokosz United States 14 379 0.7× 167 0.7× 227 1.3× 41 0.4× 60 1.5× 26 660
Marcel Mueller Switzerland 8 408 0.8× 209 0.8× 189 1.1× 113 1.2× 105 2.6× 9 800
Christoph M. Dehnhardt United States 18 641 1.2× 312 1.2× 135 0.8× 63 0.6× 31 0.8× 22 938
Jason Cellitti United States 16 640 1.2× 154 0.6× 129 0.7× 52 0.5× 16 0.4× 21 785

Countries citing papers authored by Ashok V. Purandare

Since Specialization
Citations

This map shows the geographic impact of Ashok V. Purandare's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashok V. Purandare with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashok V. Purandare more than expected).

Fields of papers citing papers by Ashok V. Purandare

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashok V. Purandare. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashok V. Purandare. The network helps show where Ashok V. Purandare may publish in the future.

Co-authorship network of co-authors of Ashok V. Purandare

This figure shows the co-authorship network connecting the top 25 collaborators of Ashok V. Purandare. A scholar is included among the top collaborators of Ashok V. Purandare based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashok V. Purandare. Ashok V. Purandare is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Purandare, Ashok V., et al.. (2023). Abstract 4004: Targeting drug-resistant acute myeloid leukemia (AML) cells using novel casein kinase II (CK2) inhibitor. Cancer Research. 83(7_Supplement). 4004–4004.
2.
Hashimoto, Ayumi, Chan Gao, Jérôme Mastio, et al.. (2018). Inhibition of Casein Kinase 2 Disrupts Differentiation of Myeloid Cells in Cancer and Enhances the Efficacy of Immunotherapy in Mice. Cancer Research. 78(19). 5644–5655. 43 indexed citations
3.
Kirov, Stefan, Heshani Desilva, Jian Cao, et al.. (2015). Sensitivity of Small Cell Lung Cancer to BET Inhibition Is Mediated by Regulation of ASCL1 Gene Expression. Molecular Cancer Therapeutics. 14(10). 2167–2174. 72 indexed citations
4.
Zimmermann, Kurt, Harold Mastalerz, Walter L. Johnson, et al.. (2015). 9H-Carbazole-1-carboxamides as potent and selective JAK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(14). 2809–2812. 10 indexed citations
5.
Purandare, Ashok V., Animesh Pardanani, Marco M. Gottardis, et al.. (2010). Characterization of BMS-911543, a Functionally Selective Small Molecule Inhibitor of JAK2. Blood. 116(21). 4112–4112. 4 indexed citations
6.
Wan, Honghe, Tram Huynh, Suhong Pang, et al.. (2009). Benzo[d]imidazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1)—Hit to Lead studies. Bioorganic & Medicinal Chemistry Letters. 19(17). 5063–5066. 45 indexed citations
7.
Purandare, Ashok V., et al.. (2009). Kinase drug discovery approaches in chronic myeloproliferative disorders. Oncogene. 28(24). 2305–2313. 25 indexed citations
8.
Huynh, Tram, Zhong Chen, Suhong Pang, et al.. (2009). Optimization of pyrazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1). Bioorganic & Medicinal Chemistry Letters. 19(11). 2924–2927. 62 indexed citations
9.
Purandare, Ashok V., Zhong Chen, Tram Huynh, et al.. (2008). Pyrazole inhibitors of coactivator associated arginine methyltransferase 1 (CARM1). Bioorganic & Medicinal Chemistry Letters. 18(15). 4438–4441. 69 indexed citations
10.
Cavallaro, Cullen L., et al.. (2007). Preparation of 2,7-Diaminosubstituted-[1,2,4]triazolo[1,5-a]pyrimidine-6-Carbonitriles by Solid-Phase Synthesis. Journal of Combinatorial Chemistry. 10(1). 28–30. 9 indexed citations
11.
Purandare, Ashok V., Honghe Wan, John E. Somerville, et al.. (2006). Core exploration in optimization of chemokine receptor CCR4 antagonists. Bioorganic & Medicinal Chemistry Letters. 17(3). 679–682. 36 indexed citations
12.
Purandare, Ashok V. & John E. Somerville. (2006). Antagonists of CCR4 as Immunomodulatory Agents. Current Topics in Medicinal Chemistry. 6(13). 1335–1344. 35 indexed citations
13.
Purandare, Ashok V., Honghe Wan, John E. Somerville, et al.. (2005). Identification of chemokine receptor CCR4 antagonist. Bioorganic & Medicinal Chemistry Letters. 15(10). 2669–2672. 54 indexed citations
14.
Purandare, Ashok V., Honghe Wan, John E. Somerville, et al.. (2005). Optimization of CCR4 antagonists: Side-chain exploration. Bioorganic & Medicinal Chemistry Letters. 16(1). 204–207. 17 indexed citations
15.
Mattson, Ronald J., Derek J. Denhart, John D. Catt, et al.. (2004). Aminotriazine 5-HT7 antagonists. Bioorganic & Medicinal Chemistry Letters. 14(16). 4245–4248. 26 indexed citations
16.
Denhart, Derek J., Ashok V. Purandare, John D. Catt, et al.. (2004). Diaminopyrimidine and diaminopyridine 5-HT7 ligands. Bioorganic & Medicinal Chemistry Letters. 14(16). 4249–4252. 10 indexed citations
17.
Purandare, Ashok V., Honghe Wan, Naomi Laing, et al.. (2004). Identification of a potent and rapidly reversible inhibitor of the 20S-proteasome. Bioorganic & Medicinal Chemistry Letters. 14(18). 4701–4704. 15 indexed citations
18.
19.
Purandare, Ashok V. & Sesha Natarajan. (1997). Synthesis of chiral α- substituted β-hydroxy acid derivatives on solid support. Tetrahedron Letters. 38(51). 8777–8780. 47 indexed citations
20.
RAO, A. V. R., et al.. (1987). Synthesis of R(+)-α-Lipoic Acid. Synthetic Communications. 17(9). 1095–1102. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. Gessier Breakdown of academic impact, for papers by Krishna G. Vijayendran Breakdown of academic impact, for papers by Shendong Yuan Breakdown of academic impact, for papers by Fabrice Pierre Breakdown of academic impact, for papers by Shaughnessy Robinson Breakdown of academic impact, for papers by Cornelis P. Vlaar Breakdown of academic impact, for papers by Laura L. Rokosz Breakdown of academic impact, for papers by Marcel Mueller Breakdown of academic impact, for papers by Christoph M. Dehnhardt Breakdown of academic impact, for papers by Jason Cellitti
Rankless by CCL
2026